Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma (Q35686880)
Jump to navigation
Jump to search
scientific article published on January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma |
scientific article published on January 2009 |
Statements
1 reference
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma (English)
1 reference
David Gandara
1 reference
Suresh S Ramalingam
1 reference
Chandra P Belani
1 reference
Christopher Ruel
1 reference
Paul Frankel
1 reference
Barbara Gitlitz
1 reference
Marianna Koczywas
1 reference
Igor Espinoza-Delgado
1 reference
1 January 2009
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference